Prevailing Antagonistic Risks in Pleiotropic Associations with Alzheimer's Disease and Diabetes.

BACKGROUND The lack of efficient preventive interventions against Alzheimer's disease (AD) calls for identifying efficient modifiable risk factors for AD. As diabetes shares many pathological processes with AD, including accumulation of amyloid plaques and neurofibrillary tangles, insulin resistance, and impaired glucose metabolism, diabetes is thought to be a potentially modifiable risk factor for AD. Mounting evidence suggests that links between AD and diabetes may be more complex than previously believed. OBJECTIVE To examine the pleiotropic architecture of AD and diabetes mellitus (DM). METHODS Univariate and pleiotropic analyses were performed following the discovery-replication strategy using individual-level data from 10 large-scale studies. RESULTS We report a potentially novel pleiotropic NOTCH2 gene, with a minor allele of rs5025718 associated with increased risks of both AD and DM. We confirm previously identified antagonistic associations of the same variants with the risks of AD and DM in the HLA and APOE gene clusters. We show multiple antagonistic associations of the same variants with AD and DM in the HLA cluster, which were not explained by the lead SNP in this cluster. Although the ɛ2 and ɛ4 alleles played a major role in the antagonistic associations with AD and DM in the APOE cluster, we identified non-overlapping SNPs in this cluster, which were adversely and beneficially associated with AD and DM independently of the ɛ2 and ɛ4 alleles. CONCLUSION This study emphasizes differences and similarities in the heterogeneous genetic architectures of AD and DM, which may differentiate the pathogenic mechanisms of these diseases.

[1]  J. Hardy,et al.  Diabetes and Alzheimer's disease: shared genetic susceptibility? , 2022, The Lancet Neurology.

[2]  S. Gharaghani,et al.  Exploring the role of non-coding RNAs as potential candidate biomarkers in the cross-talk between diabetes mellitus and Alzheimer’s disease , 2022, Frontiers in Aging Neuroscience.

[3]  A. Arnaiz-Villena,et al.  Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes , 2022, Cellular and Molecular Life Sciences.

[4]  K. Lunetta,et al.  Midlife lipid and glucose levels are associated with Alzheimer's disease , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[5]  Anonymous,et al.  2022 Alzheimer's disease facts and figures , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[6]  Liang Shen,et al.  Causal association evaluation of diabetes with Alzheimer's disease and genetic analysis of antidiabetic drugs against Alzheimer's disease , 2022, Cell & bioscience.

[7]  Liang He,et al.  Genome‐wide analysis identified abundant genetic modulators of contributions of the apolipoprotein E alleles to Alzheimer's disease risk , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[8]  A. Kulminski,et al.  Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk , 2021, Neurobiology of Aging.

[9]  Liang He,et al.  Protective association of the ε2/ε3 heterozygote with Alzheimer's disease is strengthened by TOMM40–APOE variants in men , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[10]  A. Uitterlinden,et al.  Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia , 2021, JAMA network open.

[11]  D. Nation,et al.  Role of Notch signaling in neurovascular aging and Alzheimer's disease. , 2020, Seminars in cell & developmental biology.

[12]  A. Arnaiz-Villena,et al.  HLA‐G: Function, polymorphisms and pathology , 2020, International journal of immunogenetics.

[13]  Katherine M. Siewert,et al.  Multi-trait association studies discover pleiotropic loci between Alzheimer’s disease and cardiometabolic traits , 2020, Alzheimer's Research & Therapy.

[14]  A. Esmaeili,et al.  Crosstalk between obesity, diabetes, and alzheimer’s disease: Introducing quercetin as an effective triple herbal medicine , 2020, Ageing Research Reviews.

[15]  A. Kulminski,et al.  Quantitative and qualitative role of antagonistic heterogeneity in genetics of blood lipids. , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  Piyush Gondaliya,et al.  Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease , 2019, Drug development research.

[17]  Sterling C. Johnson,et al.  Non-coding variability at the APOE locus contributes to the Alzheimer’s risk , 2019, Nature Communications.

[18]  A. Yashin,et al.  Pleiotropic Meta-Analysis of Age-Related Phenotypes Addressing Evolutionary Uncertainty in Their Molecular Mechanisms , 2019, Front. Genet..

[19]  Nick C Fox,et al.  Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing , 2019, Nature Genetics.

[20]  A. Tumminia,et al.  Type 2 Diabetes Mellitus and Alzheimer’s Disease: Role of Insulin Signalling and Therapeutic Implications , 2018, International journal of molecular sciences.

[21]  T. Chavakis,et al.  The Missed Notch to Bring Down Diabetes , 2018, Trends in Endocrinology & Metabolism.

[22]  A. Kulminski,et al.  Strong impact of natural-selection–free heterogeneity in genetics of age-related phenotypes , 2018, Aging.

[23]  Fei-fei Yan,et al.  Diabetes mellitus and Alzheimer’s disease: GSK-3β as a potential link , 2018, Behavioural Brain Research.

[24]  M. Fornage,et al.  The Alzheimer's Disease Sequencing Project: Study design and sample selection , 2017, Neurology: Genetics.

[25]  H. Deng,et al.  Linking Alzheimer's disease and type 2 diabetes: Novel shared susceptibility genes detected by cFDR approach , 2017, Journal of the Neurological Sciences.

[26]  M. Carrillo,et al.  Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative , 2016, Alzheimer's & Dementia.

[27]  Alan M. Kwong,et al.  Next-generation genotype imputation service and methods , 2016, Nature Genetics.

[28]  F. Schmitt,et al.  Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology , 2016, Alzheimer's & Dementia.

[29]  Liang Shen,et al.  Shared Genetic Etiology between Type 2 Diabetes and Alzheimer's Disease Identified by Bioinformatics Analysis. , 2015, Journal of Alzheimer's disease : JAD.

[30]  K. Hao,et al.  Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes. , 2015, Molecular aspects of medicine.

[31]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[32]  Xiaofeng Zhu,et al.  Meta-analysis of correlated traits via summary statistics from GWASs with an application in hypertension. , 2015, American journal of human genetics.

[33]  Michael W. Lutz,et al.  The cis-regulatory effect of an Alzheimer’s disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes , 2014, Alzheimer's & Dementia.

[34]  M. Goddard,et al.  A Multi-Trait, Meta-analysis for Detecting Pleiotropic Polymorphisms for Stature, Fatness and Reproduction in Beef Cattle , 2014, PLoS genetics.

[35]  S. Craft,et al.  Insulin, cognition, and dementia. , 2013, European journal of pharmacology.

[36]  L. Morelli,et al.  Notch signaling in the pathologic adult brain , 2013, Biomolecular concepts.

[37]  L. Alberi,et al.  Notch signaling in the brain: In good and bad times , 2013, Ageing Research Reviews.

[38]  J. Schneider,et al.  Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project. , 2011, Current Alzheimer research.

[39]  P. Bosco,et al.  APOE and Alzheimer disease: a major gene with semi-dominant inheritance , 2011, Molecular Psychiatry.

[40]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[41]  D. G. Clark,et al.  Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.

[42]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[43]  S. Kanba,et al.  Insulin resistance is associated with the pathology of Alzheimer disease , 2010, Neurology.

[44]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[45]  L Adrienne Cupples,et al.  Genetics Analysis Workshop 16 Problem 2: the Framingham Heart Study data , 2009, BMC proceedings.

[46]  Thomas E. Nichols,et al.  Anatomically-distinct genetic associations of APOE ɛ4 allele load with regional cortical atrophy in Alzheimer's disease , 2009, NeuroImage.

[47]  L. Fratiglioni,et al.  Mid- and Late-Life Diabetes in Relation to the Risk of Dementia , 2009, Diabetes.

[48]  R. Mayeux,et al.  Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci. , 2008, Archives of neurology.

[49]  J. Wands,et al.  Alzheimer's Disease is Type 3 Diabetes—Evidence Reviewed , 2008, Journal of diabetes science and technology.

[50]  M. McCarthy,et al.  Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes , 2008, Nature Genetics.

[51]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[52]  D. Bennett,et al.  Diabetes is related to cerebral infarction but not to AD pathology in older persons , 2006, Neurology.

[53]  T. Arendt,et al.  Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. , 2004, Cerebral cortex.

[54]  J. Shaw,et al.  Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.

[55]  Xin Xu,et al.  Combining dependent tests for linkage or association across multiple phenotypic traits. , 2003, Biostatistics.

[56]  Matthew P. Frosch,et al.  Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[57]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[58]  R. Mayeux,et al.  Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. , 2001, American journal of epidemiology.

[59]  P. Allison,et al.  Comparing Logit and Probit Coefficients Across Groups , 1999 .

[60]  A. Sharrett The Atherosclerosis Risk in Communities (ARIC) Study. Introduction and objectives of the hemostasis component. , 1992, Annals of epidemiology.

[61]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[62]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[63]  L. Grinberg,et al.  Diabetes is Not Associated with Alzheimer's Disease Neuropathology. , 2017, Journal of Alzheimer's disease : JAD.

[64]  M. Baumann,et al.  Notch signaling and ageing. , 2015, Advances in experimental medicine and biology.

[65]  C. Franceschi,et al.  An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[66]  L. Kuller,et al.  Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study. , 2008, Archives of neurology.

[67]  A. J. Slater,et al.  Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.

[68]  J. Wands,et al.  Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? , 2005, Journal of Alzheimer's disease : JAD.